KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Schrodinger (SDGR) EBT (2019 - 2025)

Schrodinger (SDGR) has disclosed EBT for 7 consecutive years, with $33.0 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 184.0% to $33.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$102.3 million, a 44.9% increase, with the full-year FY2025 number at -$102.3 million, up 44.9% from a year prior.
  • EBT was $33.0 million for Q4 2025 at Schrodinger, up from -$32.6 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $155.5 million in Q1 2023 to a low of -$64.9 million in Q3 2023.
  • A 5-year average of -$24.8 million and a median of -$35.0 million in 2021 define the central range for EBT.
  • Peak YoY movement for EBT: tumbled 7576.61% in 2022, then soared 551.13% in 2023.
  • Schrodinger's EBT stood at -$30.4 million in 2021, then increased by 10.18% to -$27.3 million in 2022, then dropped by 15.25% to -$31.5 million in 2023, then fell by 24.57% to -$39.3 million in 2024, then skyrocketed by 184.0% to $33.0 million in 2025.
  • Per Business Quant, the three most recent readings for SDGR's EBT are $33.0 million (Q4 2025), -$32.6 million (Q3 2025), and -$42.9 million (Q2 2025).